Table 1.
Lipids | Infected symptomatic individuals | Infected asymptomatic individuals | Noninfected individuals | P value | |||
---|---|---|---|---|---|---|---|
n | mg/dL | n | mg/dL | n | mg/dL | ||
TC | 17 | 121.2 ± 34.6 | 28 | 143.0 ± 42.1 | 36 | 139.9 ± 36.1 | 0.152 |
LDL-C | 17 | 59.5 ± 30.8 | 28 | 85.5 ± 42.2 | 36 | 77.1 ± 36.0 | 0.083 |
HDL-C | 17 | 38.3 ± 4.3∗ | 28 | 39.0 ± 5.8∗ | 36 | 43.0 ± 7.2 | 0.012 |
TAG | 17 | 219.4 ± 84.9∗,† | 28 | 169.1 ± 62.7 | 36 | 157.9 ± 67.6 | 0.013 |
VLDL-C | 17 | 43.8 ± 16.9∗,† | 28 | 33.9 ± 12.4 | 36 | 31.6 ± 13.5 | 0.013 |
TC = total cholesterol; LDL-C = low-density lipoprotein cholesterol; HDL-C = density lipoprotein cholesterol; TAG = triacylglycerol; VLDL = very-low-density lipoprotein cholesterol. Lipid values expressed as the mean ± SD. P value analyzed by ANOVA test with the Student Newman-Keuls posttest. *P < 0.05 versus noninfected individuals; † P < 0.05 versus infected asymptomatic individuals. P values in bold indicate statistically significant differences.